A major contributor to this article appears to have a close connection with its subject.(June 2018) |
Formation | 1996 |
---|---|
Headquarters | Grand Rapids, Michigan |
CEO | David Van Andel |
Staff | >500 |
Website | www |
Van Andel Institute(VAI) is a 501(c)(3) nonprofit biomedical research and science education organization in Grand Rapids, Michigan. VAI was founded by Jay and Betty Van Andel in 1996. [1]
The institute's research focuses on cancer epigenetics and Parkinson's disease. Its educational efforts support teacher development and science education from early elementary through the doctoral level.
David Van Andel, son of Jay and Betty, has been CEO and chairman since 1996. [2]
Van Andel Research Institute (VARI) scientists study the epigenetic, genetic, cellular and structural basis of cancer and Parkinson's disease as well as osteoarthritis, neurofibromatosis type 1, Alzheimer's disease, prion diseases, Ewing sarcoma and other conditions. [3]
As of 2023, Van Andel Institute has more than 500 employees.
The Center for Epigenetics [4] was established in 2014 and is led by Peter Jones. [5] Scientists in the Center focus on identifying epigenetic mechanisms in health and disease states, and translating their findings into new treatments for cancer and neurodegenerative diseases.
The Center for Neurodegenerative Science was established in 2012. [6] The center primarily investigates the underlying causes of Parkinson's disease. [7]
The Center for Cancer and Cell Biology [4] is led by Bart Williams. [8] It is the largest center at the institute. [4]
The institute's laboratories are supported by a Core Technologies and Services group that comprises eight shared scientific services: [9]
In 2017, the institute established the David Van Andel Advanced Cryo-Electron Microscopy Suite as part of an expansion of its structural biology program. [10] [11] The $10 million investment included the installation of an FEI Titan Krios cryo-electron microscope, a Talos Arctica cryo-electron microscope and a Tecnai Spirit G2 BioTWIN screening microscope. [10]
The institute also houses a College of American Pathologists-accredited Biorepository [12] that contains more than one million formalin-fixed paraffin-embedded blocks.
Grand River Aseptic Manufacturing (GRAM) was founded in 2010 by Van Andel Institute and Grand Valley State University. Much of GRAM's initial funding was through angel investment that generated $5 million in 2010 and another $2 million in 2013. [13]
In September 2014, the institute partnered with The Cure Parkinson's Trust on its Linked Clinical Trials initiative, which investigates repurposed drugs for use as disease-modifying treatments for Parkinson's. [14] LCT has supported trials in ambroxol, exenatide, simvastatin, liraglutide, and others. [15]
In October, the institute announced a partnership with Stand Up To Cancer to form the VARI–SU2C Epigenetics Dream Team, a multi-institutional collaboration to translate potential epigenetic treatments for cancer into clinical trials. [16] [17] The team is led by Jones and Stephen Baylin, M.D co-head of the Cancer Biology Program at Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center. It has launched six clinical trials in cancers, including metastatic colorectal cancer, myelodysplastic syndrome, acute myeloid leukemia, non-small cell lung cancer, and bladder cancer.
In 1999, George Vande Woude, joined VARI [18] as its founding research director. He previously was director of the Basic Research Program at the Frederick Cancer Research and Development Center as well as the director for the Division of Basic Sciences at the National Cancer Institute. In the early 1980s, Vande Woude's laboratory discovered the human MET oncogene, which is now an important target in the development of anti-cancer drugs. [19] He stepped down from his post as research director in 2009 to devote more time to his research. He was a Distinguished Scientific Fellow at VARI and was a fellow of the National Academy of Sciences and the American Association for the Advancement of Science. [20]
Vande Woude was succeeded by Jeffrey Trent, who had a dual role as research director at VARI and at Translational Genomics Research Institute (TGen) in Phoenix, Arizona. [21] Trent founded TGen in 2002 [22] after 10 years at the National Human Genome Research Institute, a part of the National Institutes of Health. He left VARI in 2012 to lead TGen full-time. [23]
In 2013, Peter Jones, was named as the institute's chief scientific officer after 37 years at the University of Southern California, where he most recently was director of USC's Norris Comprehensive Cancer Center from 1993 to 2011. [24] [25] [26] Jones's work helped established the field of epigenetics, particularly his seminal 1980 discovery that DNA methylation impacts gene expression and cellular differentiation. [5] He is past president of the American Association for Cancer Research [27] and is an elected fellow of the National Academy of Sciences, [28] the American Academy of Arts and Sciences, [29] the American Association for the Advancement of Science [30] and the American Association for Cancer Research Academy. [31] Jones also is director of the institute's Center for Epigenetics.
Van Andel Education Institute (VAEI), founded in 1996, [32] provides kindergarten to 12th-grade inquiry-based science education programs for students, and sustained professional development programs and instructional tools for educators.
Gordon Van Wylen was appointed director of VAEI in 1996. [33] Before workthis, Van Wylen was elected dean of the Engineering Department at the University of Michigan in 1965 [34] and later served as president of Hope College in Holland, Michigan, from 1972 to 1987. [35]
Gordon Van Harn was appointed director of VAEI in 2001 and worked in this capacity until 2009. [36] Van Harn was also an emeritus provost and professor of biology at Calvin College [37] in Grand Rapids, Michigan.
Marcia Bishop was appointed associate director of VAEI in 2004. [38] She was in this role until 2011 when Jim Nicolette was appointed to the position of associate director. [39]
Steven J. Triezenberg was director of VAEI between 2009 and 2015. Triezenberg previously was a faculty member of the Department of Biochemistry and Molecular Biology at Michigan State University for more than 18 years. [40]
Terra Tarango was appointed director of VAEI in 2016. [41] Tarango previously held the position of president of Staff Development for Educators (SDE), a professional development company in New Hampshire, from 2012 to 2016. [41] Tarango also designed print and digital curriculum for kindergarten through 12th-grade students at Houghton Mifflin Harcourt. [41]
VAEI's student programs for kindergarten through 12th grade students include: [42]
VAEI designs and provides professional development workshops and instructional tools for kindergarten through twelfth grade teachers. [43] Materials include downloadable lesson plans, interactive student journals, and classroom resources.
In 2015, [44] VAEI launched NexGen Inquiry, a web-based instructional tool designed to help students and teachers meet Next Generation Science Standards (NGSS) as well as other state benchmarks, and provides teachers with the tools they need to incorporate inquiry-based learning in their classrooms. [44]
Van Andel Institute Graduate School (VAIGS) offers an accredited program in cell and molecular genetics that is designed to foster problem-based thinking and research leadership. VAIGS also offers an M.D./Ph.D. program in partnership with Michigan State University College of Human Medicine [45] and Western Michigan University Homer Stryker M.D. Medical School. [46]
VAIGS was founded in 2005 [33] under the leadership of then-VAEI director Gordon Van Harn, . The first graduating class was in 2012. VAIGS was accredited by the HLC on November 12, 2013. [47] Steven J. Triezenberg, was named the founding dean in 2006. [33]
Purple Community, founded in 2009, [48] is Van Andel Institute's grassroots community awareness and fundraising program. Purple Community helps individuals and organizations create fundraising events to support biomedical research and science education at Van Andel Institute. [48]
Van Andel Institute is located on the Grand Rapids Medical Mile. Its 400,000 square foot building [49] was designed by architect Rafael Viñoly and was constructed in two phases; [50] the first phase was completed in 2000 [51] and second phase opened in December 2009. [52] It includes 27,500 square feet of laboratory space, 71,000 square feet of laboratory support space, a demonstration lab, an auditorium and on-site cafeteria. The institute's Phase II was awarded Leadership in Energy & Environmental Design (LEED) Platinum status by the United States Green Building Council in 2011. [53]
The lobby features a 14-foot tall glass sculpture called "Life" [54] created by Dale Chihuly designed to be an artistic representation of a DNA double helix.
WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.
Jay Van Andel was an American billionaire businessman, best known as co-founder of the Amway Corporation, along with Richard DeVos.
John Hoult Logie was an American attorney and politician who served as mayor of Grand Rapids, Michigan from 1992 to 2003, one of the longest-serving in the city's history.
Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.
The Translational Genomics Research Institute (TGen)
Ralph Hauenstein was an American philanthropist, army officer and business leader, best known as a newspaper editor. His leadership has produced institutions such as the Hauenstein Center for Presidential Studies at Grand Valley State University, the Hauenstein Parkinsons and Neuroscience Centers at Saint Mary's Hospital and the Grace Hauenstein Library at Aquinas College.
Grand Rapids Medical Mile is a designated area within the city of Grand Rapids, Michigan. It began with medical-related development in the Hillside District of Grand Rapids, bordering both sides of Michigan Street. More than a decade later it encompasses an area five times larger, expanding east further down Michigan St.and north across Interstate 196. It has also been referred to as Grand Rapids Medical Corridor, Michigan Street Medical Corridor, Health Hill, Medical Hill, and Pill Hill, among other names.
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee's significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.
Andrew John Lees FRCP FRCP(G) FMedSci is Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world's most highly cited Parkinson's disease researcher.
Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences. He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences. Zhou is an elected fellow of the American Association for the Advancement of Science.
Andrew B. Singleton is a British neurogeneticist currently working in the USA. He was born in Guernsey, the Channel Islands in 1972, where he lived until he was 18 years old. His secondary education was conducted at the Guernsey Grammar School. He earned a first class degree in Applied Physiology from Sunderland University and his PhD in neuroscience from the University of Newcastle upon Tyne where he studied the genetics of Alzheimer's disease and other dementias at the Medical Research Council (MRC) Neurochemical Pathology Unit. He moved to the United States in 1999, where he began working at the Mayo Clinic in Jacksonville, Florida studying the genetic basis of Parkinson's disease, ataxia, and dystonia. He moved to the National Institutes of Health in 2001 to head the newly formed Molecular Genetics unit within the Laboratory of Neurogenetics. In 2006 he took over as Chief of the Laboratory of Neurogenetics and became an NIH Distinguished Investigator in the intramural program at the National Institute on Aging (NIA) in 2017. In 2020 he stepped down as the Chief of the Laboratory of Neurogenetics and became the Acting Director of the newly formed Center for Alzheimer's and Related Dementias at the NIA. In 2021 he became the Director of CARD.
Tapas Kumar Kundu is an Indian molecular biologist, academician and at present the Director of Central Drug Research Institute, a prestigious research institute of Council of Scientific and Industrial Research at Lucknow. He is the head of the Transcription and Disease Laboratory of Jawaharlal Nehru Centre for Advanced Scientific Research. He is known for his studies on the regulation of Gene expression and his contributions in cancer diagnostics and the development of new drug candidates for cancer and AIDS therapeutics. He is an elected fellow of the Indian Academy of Sciences, Indian National Science Academy and the National Academy of Sciences, India and a J. C. Bose National Fellow of the Department of Science and Technology. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2005, for his contributions to biological sciences. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology.
George F. Vande Woude Jr. was an American cancer researcher, who, from 1999 to 2009, served as the founding director of research at the Van Andel Institute (VAI). He is credited with the 1984 discovery of MET, an oncogene.
Jeffrey M. Trent is the founding president and director of the Translational Genomics Research Institute. He has been vice president and Research Director of the Van Andel Institute since 2009. He was the founding director of NIH's National Human Genome Research Institute in 1993.
Stephen Bruce Baylin is the deputy director and associate director for research at the Sidney Kimmel Comprehensive Cancer Center and Virginia and D.K. Ludwig Professor for Cancer Research and medicine and chief of cancer biology of the Johns Hopkins University School of Medicine. His research focus is epigenetics in the development of cancer, and he was one of the first researchers in this field in the 1980s.
Nita Ahuja is a surgeon and the Chair of the Department of Surgery at Yale School of Medicine and Surgeon-in-Chief of Surgery at Yale New Haven Hospital. She is the first woman ever to serve as Chair of Surgery in Yale in its >200 year history. Before taking this position she was the first woman ever to be the Chief of Surgical Oncology at Johns Hopkins Hospital, Baltimore, USA. Ahuja researches in the field of epigenetics and is a passionate advocate of clinician scientist. She also served as the director of Sarcoma and peritoneal surface malignancy program. She is a surgeon-scientist and her research has been cited more than 11,000 times in scientific literature.
Sara A. Courtneidge is a cancer research scientist.
Patrik Brundin is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F. Hoffmann-La Roche, Pharmaceutical Research and Early Development (pRED).
Nancy M. Bonini is an American neuroscientist and geneticist, best known for pioneering the use of Drosophila as a model organism to study neurodegeneration of the human brain. Using the Drosophila model approach, Bonini's laboratory has identified genes and pathways that are important in the development and progression of neurodegenerative diseases such as Amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease, as well as aging, neural injury and regeneration, and response to environmental toxins.
Susan VandeWoude is an American veterinarian and researcher specializing in viral diseases of cats. She is currently serving as the Dean of Colorado State University's College of Veterinary Medicine and Biomedical Sciences and a member of the National Academy of Sciences.